Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)
Clinical trial NCT04574830 · COMPLETED
Trial details
- NCT number
- NCT04574830
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-11-23
- Primary completion
- 2022-06-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.